@Michael-official The company is relatively new and focuses on using AI to recognize and cure diseases more quickly. To this end, the company is developing a platform that evaluates typical disease patterns, for example, in order to provide an accurate diagnosis with a low error rate
@[McCrispy](McCrispy) Who would be the target group for such a platform?
The Pfizer's, Merck's and Co of this world, who develop drugs and bring them to market, have collected this data themselves in the course of their research and test studies and also make it available to their customers such as doctors and hospitals. The question for me is who should rely on results and recommendations from such a third-party platform? And where does a newcomer get this sensitive data from? But I'm not an expert in this area either...
